HEADER ANTIBIOTIC 22-DEC-00 1HHC TITLE CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P21, SECOND FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: DECAPLANIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: M86-1410 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: UNCULTURED ACTINOMYCETE; SOURCE 3 ORGANISM_TAXID: 100235; SOURCE 4 STRAIN: DSM 4763; SOURCE 5 OTHER_DETAILS: CULTURE HIL Y-86, 36910 KEYWDS ANTIBIOTIC, GLYCOPEPTIDE EXPDTA X-RAY DIFFRACTION AUTHOR C.LEHMANN,L.VERTESSY,G.M.SHELDRICK,Z.DAUTER,M.DAUTER REVDAT 8 13-DEC-23 1HHC 1 HETSYN LINK REVDAT 7 29-JUL-20 1HHC 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE ATOM REVDAT 6 24-APR-19 1HHC 1 REMARK SEQRES LINK REVDAT 5 01-MAY-13 1HHC 1 HETSYN REVDAT 4 25-JUL-12 1HHC 1 REMARK HET HETNAM SITE REVDAT 4 2 1 HETATM ANISOU REVDAT 3 13-JUL-11 1HHC 1 VERSN REVDAT 2 24-FEB-09 1HHC 1 VERSN REVDAT 1 11-JUL-05 1HHC 0 JRNL AUTH C.LEHMANN,J.E.DEBRECZENI,G.BUNKOCZI,M.DAUTER,Z.DAUTER, JRNL AUTH 2 L.VERTESY,G.M.SHELDRICK JRNL TITL STRUCTURES OF FOUR CRYSTAL FORMS OF DECAPLANIN JRNL REF HELV.CHIM.ACTA V. 86 1478 2003 JRNL REFN ISSN 0018-019X JRNL DOI 10.1002/HLCA.200390131 REMARK 2 REMARK 2 RESOLUTION. 1.13 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.13 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.224 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.222 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1901 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 38893 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.185 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.183 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1425 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 29332 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 313 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 153 REMARK 3 SOLVENT ATOMS : 163 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 623.50 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 5685 REMARK 3 NUMBER OF RESTRAINTS : 1007 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.042 REMARK 3 ANGLE DISTANCES (A) : 0.041 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.076 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.096 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.146 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.014 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.011 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.084 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HHC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-DEC-00. REMARK 100 THE DEPOSITION ID IS D_1290005724. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-98 REMARK 200 TEMPERATURE (KELVIN) : 133.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : SEALED TUBE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS-STOE-HUBER REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.71073 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT REMARK 200 DATA SCALING SOFTWARE : SADABS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20450 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.130 REMARK 200 RESOLUTION RANGE LOW (A) : 18.080 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 7.140 REMARK 200 R MERGE (I) : 0.09810 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.3400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.13 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.30200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.670 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: PDB ENTRY 1HH3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1M NA3CIT PH=7.0, PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 15.95400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. REMARK 400 HERE, DECAPLSNIN IS REPRESENTED BY GROUPING TOGETGHER THE REMARK 400 SEQUENCE (SEQRES) AND THE THREE LIGANDS (HET) BGC, ERE AND RAM. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DECAPLANIN REMARK 400 CHAIN: A, B, C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 7 REMARK 400 COMPONENT_2: SUGAR RESIDUES 8, 9 AND 10 REMARK 400 DESCRIPTION: DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. REMARK 400 THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE REMARK 400 CONFIGURATION D-D-L-D-D-L-L, GLYCOSYLATED REMARK 400 BY A MONOSACCHARIDE AND A DISACCHARIDE REMARK 400 REMARK 400 THE DECAPLANIN IS GLYCOPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DECAPLANIN REMARK 400 CHAIN: A, B, C, D, E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 COMPONENT_2: RESIDUE BGC REMARK 400 COMPONENT_3: RESIDUE ERE REMARK 400 COMPONENT_4: RESIDUE RAM REMARK 400 DESCRIPTION: DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD REMARK 400 IS A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L- REMARK 400 L, GLYCOSYLATED REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MLU B 1 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 OMZ B 2 O - C - N ANGL. DEV. = -12.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN C 3 -61.12 -95.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CIT C 1003 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HH3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P21 REMARK 900 RELATED ID: 1HHA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P6122 REMARK 900 RELATED ID: 1HHF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P6122, SECOND FORM DBREF 1HHC A 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HHC B 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HHC C 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HHC D 1 7 NOR NOR00692 NOR00692 1 7 SEQRES 1 A 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 B 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 C 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 D 7 MLU OMZ ASN GHP GHP OMX 3FG MODRES 1HHC OMX A 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HHC OMX B 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HHC OMX C 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HHC OMX D 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE HET MLU A 1 9 HET OMZ A 2 14 HET GHP A 4 11 HET GHP A 5 11 HET OMX A 6 13 HET 3FG A 7 13 HET MLU B 1 6 HET OMZ B 2 14 HET GHP B 4 11 HET GHP B 5 11 HET OMX B 6 13 HET 3FG B 7 13 HET MLU C 1 9 HET OMZ C 2 14 HET GHP C 4 11 HET GHP C 5 11 HET OMX C 6 13 HET 3FG C 7 13 HET MLU D 1 9 HET OMZ D 2 14 HET GHP D 4 11 HET GHP D 5 11 HET OMX D 6 13 HET 3FG D 7 13 HET BGC E 1 11 HET RAM E 2 10 HET BGC F 1 11 HET RAM F 2 10 HET BGC G 1 11 HET RAM G 2 10 HET BGC H 1 11 HET RAM H 2 10 HET ERE A 8 10 HET CIT A1002 13 HET ERE B 8 10 HET ERE C 8 10 HET CIT C1003 3 HET ERE D 8 10 HET CIT D1001 13 HETNAM MLU N-METHYL-D-LEUCINE HETNAM OMZ (BETAR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE HETNAM GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID HETNAM OMX (BETAR)-BETA-HYDROXY-L-TYROSINE HETNAM 3FG (2S)-AMINO(3,5-DIHYDROXYPHENYL)ETHANOIC ACID HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM RAM ALPHA-L-RHAMNOPYRANOSE HETNAM ERE 4-EPI-VANCOSAMINE HETNAM CIT CITRIC ACID HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN RAM ALPHA-L-RHAMNOSE; 6-DEOXY-ALPHA-L-MANNOPYRANOSE; L- HETSYN 2 RAM RHAMNOSE; RHAMNOSE HETSYN ERE (1R,3S,4R,5S)-3-AMINO-2,3,6-TRIDEOXY-3-METHYL-ALPHA-L- HETSYN 2 ERE ARABINO-HEXOPYRANOSE FORMUL 1 MLU 4(C7 H15 N O2) FORMUL 1 OMZ 4(C9 H10 CL N O4) FORMUL 1 GHP 8(C8 H9 N O3) FORMUL 1 OMX 4(C9 H11 N O4) FORMUL 1 3FG 4(C8 H9 N O4) FORMUL 5 BGC 4(C6 H12 O6) FORMUL 5 RAM 4(C6 H12 O5) FORMUL 9 ERE 4(C7 H15 N O3) FORMUL 10 CIT 3(C6 H8 O7) FORMUL 16 HOH *163(H2 O) LINK C MLU A 1 N OMZ A 2 1555 1555 1.34 LINK C OMZ A 2 N ASN A 3 1555 1555 1.34 LINK OH OMZ A 2 C5 GHP A 4 1555 1555 1.39 LINK C ASN A 3 N GHP A 4 1555 1555 1.37 LINK C GHP A 4 N GHP A 5 1555 1555 1.33 LINK C3 GHP A 4 OH OMX A 6 1555 1555 1.42 LINK O4 GHP A 4 C1 BGC E 1 1555 1555 1.44 LINK C GHP A 5 N OMX A 6 1555 1555 1.32 LINK C3 GHP A 5 CG1 3FG A 7 1555 1555 1.49 LINK C OMX A 6 N 3FG A 7 1555 1555 1.36 LINK OC OMX A 6 C1 ERE A 8 1555 1555 1.42 LINK C MLU B 1 N OMZ B 2 1555 1555 1.36 LINK C OMZ B 2 N ASN B 3 1555 1555 1.28 LINK OH OMZ B 2 C5 GHP B 4 1555 1555 1.39 LINK C ASN B 3 N GHP B 4 1555 1555 1.33 LINK C GHP B 4 N GHP B 5 1555 1555 1.36 LINK C3 GHP B 4 OH OMX B 6 1555 1555 1.38 LINK O4 GHP B 4 C1 BGC F 1 1555 1555 1.41 LINK C GHP B 5 N OMX B 6 1555 1555 1.33 LINK C3 GHP B 5 CG1 3FG B 7 1555 1555 1.48 LINK C OMX B 6 N 3FG B 7 1555 1555 1.36 LINK OC OMX B 6 C1 ERE B 8 1555 1555 1.42 LINK C MLU C 1 N OMZ C 2 1555 1555 1.35 LINK C OMZ C 2 N ASN C 3 1555 1555 1.34 LINK OH OMZ C 2 C5 GHP C 4 1555 1555 1.39 LINK C ASN C 3 N GHP C 4 1555 1555 1.33 LINK C GHP C 4 N GHP C 5 1555 1555 1.36 LINK C3 GHP C 4 OH OMX C 6 1555 1555 1.39 LINK O4 GHP C 4 C1 BGC G 1 1555 1555 1.44 LINK C GHP C 5 N OMX C 6 1555 1555 1.31 LINK C3 GHP C 5 CG1 3FG C 7 1555 1555 1.50 LINK C OMX C 6 N 3FG C 7 1555 1555 1.36 LINK OC OMX C 6 C1 ERE C 8 1555 1555 1.40 LINK C MLU D 1 N OMZ D 2 1555 1555 1.33 LINK C OMZ D 2 N ASN D 3 1555 1555 1.33 LINK OH OMZ D 2 C5 GHP D 4 1555 1555 1.39 LINK C ASN D 3 N GHP D 4 1555 1555 1.35 LINK C GHP D 4 N GHP D 5 1555 1555 1.33 LINK C3 GHP D 4 OH OMX D 6 1555 1555 1.40 LINK O4 GHP D 4 C1 BGC H 1 1555 1555 1.40 LINK C GHP D 5 N OMX D 6 1555 1555 1.33 LINK C3 GHP D 5 CG1 3FG D 7 1555 1555 1.50 LINK C OMX D 6 N 3FG D 7 1555 1555 1.35 LINK OC OMX D 6 C1 ERE D 8 1555 1555 1.41 LINK O2 BGC E 1 C1 RAM E 2 1555 1555 1.42 LINK O2 BGC F 1 C1 RAM F 2 1555 1555 1.41 LINK O2 BGC G 1 C1 RAM G 2 1555 1555 1.41 LINK O2 BGC H 1 C1 RAM H 2 1555 1555 1.41 CISPEP 1 GHP A 5 OMX A 6 0 6.02 CISPEP 2 GHP B 5 OMX B 6 0 10.01 CISPEP 3 GHP C 5 OMX C 6 0 7.39 CISPEP 4 GHP D 5 OMX D 6 0 8.34 CRYST1 28.945 31.908 34.735 90.00 109.87 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.034548 0.000000 0.012486 0.00000 SCALE2 0.000000 0.031340 0.000000 0.00000 SCALE3 0.000000 0.000000 0.030612 0.00000 MTRIX1 1 -0.966650 -0.178880 -0.183300 0.07411 1 MTRIX2 1 -0.140040 -0.230070 0.963050 -26.26217 1 MTRIX3 1 -0.214440 0.956590 0.197350 20.64583 1 MTRIX1 2 0.761130 0.004130 0.648580 -14.32841 1 MTRIX2 2 -0.035650 -0.998200 0.048190 12.11362 1 MTRIX3 2 0.647610 -0.059800 -0.759620 40.40091 1 MTRIX1 3 -0.851290 0.246660 -0.463110 3.44473 1 MTRIX2 3 0.502150 0.127030 -0.855400 12.69141 1 MTRIX3 3 -0.152170 -0.960740 -0.232000 43.50352 1 HETATM 1 N MLU A 1 2.375 -5.025 38.527 1.00 6.34 N ANISOU 1 N MLU A 1 1432 544 433 -153 -70 56 N HETATM 2 CN MLU A 1 2.317 -3.626 39.070 1.00 7.72 C ANISOU 2 CN MLU A 1 1697 533 704 -208 -325 0 C HETATM 3 CA MLU A 1 1.961 -5.100 37.082 1.00 6.30 C ANISOU 3 CA MLU A 1 1350 566 478 -168 -141 95 C HETATM 4 C MLU A 1 3.068 -4.388 36.321 1.00 6.12 C ANISOU 4 C MLU A 1 1242 649 436 -28 -80 96 C HETATM 5 O MLU A 1 4.221 -4.757 36.352 1.00 7.06 O ANISOU 5 O MLU A 1 1266 874 542 29 -194 345 O HETATM 6 CB MLU A 1 1.830 -6.602 36.792 1.00 7.25 C ANISOU 6 CB MLU A 1 1613 568 574 -144 -450 87 C HETATM 7 CG MLU A 1 1.424 -6.896 35.299 1.00 8.20 C ANISOU 7 CG MLU A 1 1709 735 673 -70 -615 10 C HETATM 8 CD1 MLU A 1 -0.009 -6.444 35.121 1.00 9.89 C ANISOU 8 CD1 MLU A 1 1603 1157 998 -173 -649 -26 C HETATM 9 CD2 MLU A 1 1.643 -8.287 34.894 1.00 11.79 C ANISOU 9 CD2 MLU A 1 2606 866 1009 132 -1035 -257 C HETATM 10 N OMZ A 2 2.646 -3.332 35.619 1.00 5.27 N ANISOU 10 N OMZ A 2 993 588 423 1 58 53 N HETATM 11 CA OMZ A 2 3.642 -2.523 34.944 1.00 5.10 C ANISOU 11 CA OMZ A 2 903 594 442 38 71 23 C HETATM 12 C OMZ A 2 3.263 -2.066 33.545 1.00 4.68 C ANISOU 12 C OMZ A 2 790 567 421 -8 99 7 C HETATM 13 O OMZ A 2 4.045 -1.300 32.933 1.00 5.33 O ANISOU 13 O OMZ A 2 858 581 585 12 139 111 O HETATM 14 CB OMZ A 2 4.057 -1.279 35.795 1.00 5.24 C ANISOU 14 CB OMZ A 2 983 581 427 15 -21 72 C HETATM 15 OC OMZ A 2 4.455 -1.762 37.113 1.00 5.99 O ANISOU 15 OC OMZ A 2 1143 708 424 43 -36 93 O HETATM 16 CG OMZ A 2 2.952 -0.259 35.931 1.00 4.93 C ANISOU 16 CG OMZ A 2 893 525 457 -71 -16 -4 C HETATM 17 CD1 OMZ A 2 2.976 0.891 35.200 1.00 4.32 C ANISOU 17 CD1 OMZ A 2 841 451 348 -55 15 -97 C HETATM 18 CD2 OMZ A 2 1.818 -0.535 36.659 1.00 5.06 C ANISOU 18 CD2 OMZ A 2 906 495 520 -143 -9 -18 C HETATM 19 CE1 OMZ A 2 1.950 1.798 35.153 1.00 4.65 C ANISOU 19 CE1 OMZ A 2 873 439 455 -38 49 -134 C HETATM 20 CL OMZ A 2 1.953 3.225 34.171 1.00 6.97 CL ANISOU 20 CL OMZ A 2 1295 581 772 4 123 150 CL HETATM 21 CE2 OMZ A 2 0.773 0.358 36.662 1.00 5.11 C ANISOU 21 CE2 OMZ A 2 894 490 560 -152 34 -123 C HETATM 22 CZ OMZ A 2 0.783 1.452 35.841 1.00 4.93 C ANISOU 22 CZ OMZ A 2 872 466 536 -44 74 -147 C HETATM 23 OH OMZ A 2 -0.348 2.235 35.691 1.00 5.29 O ANISOU 23 OH OMZ A 2 889 516 606 -3 61 -242 O